PATIENT PORTAL 401.444.7959

Clinical Trials

Alopecia Areata

Brown Dermatology is working on getting new Alopecia trials to offer our patients. If you would like to be contacted about upcoming trials, please contact Taylor Kells at (401) 606-4697

Atopic Dermatitis

The purpose of this research study is to assess the efficacy and safety of the study drug, Upadacitinib combined with topical corticosteroids for the treatment of adolescent and adult subjects with moderate to severe AD who are candidates for systemic therapy. For further information, please contact Taylor Kells at (401) 606-4697.

Another AD trial is to compare the effects of the study drug, PF‑04965842, with a placebo to find out which is better for treating atopic dermatitis. PF-04965842 is a blocker of an enzyme called Janus kinase, which acts like a switch for the cells of the immune system (the body’s defense against infection and inflammation).  By turning off this switch, the cells of the immune system are expected to produce fewer chemicals believed to cause atopic dermatitis. We are looking for adolescents age 12–18 years of age. For further information, please contact Taylor Kells at (401) 606-4697.

Moles Self Imaging

The study involves the evaluation of the utility and efficacy of the Self-Imaging of Moles (SIM) Method as a body photography tool to be used in a remote setting to rapidly and accurately assess the number of nevi a patient has on a body site of interest. Patients must be at least 18 and own a personal cell phone with a camera. For further information, please contact Mahroo Tajalli (401) 606-4696.

Psoriasis

This study involves evaluating the efficacy of study drug (JTE-451) administered for 16 weeks in subjects with moderate to severe plaque psoriasis compared with placebo. For further information, please contact Taylor Kells at (401) 606-4697.

Psoriasis Registry

The study involves the creation of a registry of patients with psoriasis whom were started or plan to be started on a new biological medication in the past 12 months.  Patients must be over 18 years old and diagnosed by a Dermatologist with psoriasis. Patients must be started on or switched to a biological medication within the last 12 months. Patients must be willing to fill out questionnaires every 6-18 months. For further information, please contact Taylor Kells at (401) 606-4697.

Psoriatic Arthritis

The purpose of this research study is to evaluate the efficacy and safety of apremilast (CC-10004) in those with early, oligoarticular psoriatic arthritis despite initial stable treatment with either non-steroidal anti-inflammatory drugs (NSAIDs) and/or 1 conventional synthetic disease-modifying antirheumatic drugs (DMARD). Psoriatic arthritis (PsA) is a heterogeneous inflammatory rheumatologic disorder characterized by inflammatory arthritis affecting 6% to 39% of patients suffering from psoriasis. For further information, please contact Taylor Kells at (401) 606-4697.

Psoriasis Self Imaging

The study involves the evaluation of the utility and efficacy of the Psoriatic Self-Photography Method (PSPM) as a body photography tool to be used in the patient home setting for providers to dynamically monitor lesions and assess the extent and severity of disease. Patients must be at least 18 years old, be diagnosed by a Dermatologist with psoriasis and own a personal cell phone with a camera. For further information, please contact Mahroo Tajalli (401) 606-4696.

Skin Disease Biorepository

A registry for new and existing patients 18 years of age and older, seen for treatment and follow-up of their diagnosed skin disease, such as skin cancer, psoriatic arthritis, psoriasis, vitiligo, hidradenitis suppurativa, atopic dermatitis, alopecia areata, atypical nevi, cutaneous lupus erythematosus, dermatomyositis, scleroderma, pemphigoid and lichen planus. This study will take place at the Brown Dermatology clinic at 593 Eddy Street, APC-10 and satellite offices and at the outpatient dermatology clinics at LPG Dermatology, 950 Warren Avenue. The collected information will help physicians better understand, prevent and diagnose, or treat a variety of diseases and conditions. For further information, please contact Morganne Adroved at (401) 444-7853.